Sentreas Sanks, 36, of Mansfield, was sentenced Tuesday to the maximum 35.5 years in prison. He was convicted on 14 of 18 counts during trial.
A federal judge in Louisiana heard arguments on Tuesday challenging a mail-order abortion drug rule, finalized in 2023 by ...
WASHINGTON, Feb 13 (Reuters) - The Trump administration could take action including an injunction or fines against online telehealth company Hims for intending to sell a compounded version of Novo ...
Over the weekend Lenny Zhou, a councillor with Vancouver's majority ABC party, posted a video to WeChat accusing the four city councillors who aren't part of the party of using and dealing drugs, a ...
Federal authorities on Thursday arrested 12 alleged members and associates of the 18th Street Gang, accusing them of controlling MacArthur Park as an open-air drug marketplace, where fentanyl and ...
The U.S. Food and Drug Administration said on Friday it would take action against telehealth provider Hims & Hers for its $49 weight-loss pill, including restricting access to the drug's ingredients ...
When Trump’s top health goon was tasked with answering for the president’s brutal immigration crackdowns, he placed the blame on the press for amplifying “Trump derangement syndrome.” Robert F.
Bringing criminal cases against Cuban leaders could provide a legal and political pretext for such action, just as the Justice Department’s indictment against Venezuela’s president, Nicolás Maduro, ...
Netflix is a goldmine for crime dramas. Here are the 10 greatest and most riveting crime shows viewers can binge on Netflix right now.
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
E! News on MSN
Sean "Diddy" Combs Gets Prison Release Date Moved Up
Sean "Diddy" Combs' new release date has been set for April 25, 2028, according to Bureau of Prisons records viewed by E!
With online health and wellness company Hims & Hers opening a new front in the GLP-1 compounding showdown Thursday, the United States’ top drug regulator has taken notice. “FDA will take swift action ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results